DNB Asset Management Reduces McKesson Stake

Institutional investor sells 3,320 shares of pharmaceutical distributor

Published on Feb. 28, 2026

Got story updates? Submit your updates here. ›

DNB Asset Management AS, a Norwegian investment management firm, reduced its position in shares of McKesson Corporation (NYSE: MCK) by 7.0% during the 3rd quarter, according to a recent 13F filing with the Securities & Exchange Commission. The firm now owns 43,957 shares of the company's stock, valued at $33,959,000 as of the filing.

Why it matters

As a major institutional investor, changes in DNB Asset Management's holdings can provide insight into market sentiment and investor confidence around McKesson, a leading pharmaceutical distribution company. The reduction, while relatively small, may signal broader concerns or portfolio rebalancing by the firm.

The details

According to the 13F filing, DNB Asset Management sold 3,320 shares of McKesson during the 3rd quarter. The firm now holds 43,957 shares of the company's stock, down from 47,277 shares previously. McKesson's stock price has seen strong performance over the past year, rising over 25% as of the most recent quarter.

  • DNB Asset Management filed the 13F report disclosing the stake reduction in the 3rd quarter of 2026.

The players

DNB Asset Management AS

A Norwegian investment management firm that reduced its position in McKesson Corporation.

McKesson Corporation

A global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions.

Got photos? Submit your photos here. ›

The takeaway

The reduction in DNB Asset Management's McKesson holdings, while relatively small, could signal broader concerns or portfolio rebalancing by the institutional investor. As a major pharmaceutical distributor, changes in McKesson's shareholder base are closely watched by industry analysts.